Parliamentary Search

1-20 of 77 results for subject:Patients

Answering member X
Baroness Thornton

Type

House

Session

Year

Department

Member

Primary member

Answering member

More
Thornton, Baroness (77)

Legislative stage

Legislation

Subject

More

Publisher

Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first
Health and Care Bill

Lords consideration of Commons amendments and reasons. Lords amendment 11 not insisted on and Commons amendment 11A in lieu agreed to. Lords amendment 29 not insisted on and Lords amendment 29B in lieu agreed to on division (187 to 151). Lords amendments 30 and 108 not insisted on and Lords...
Lead member
Lord Kamall; Earl Howe; Baroness Penn
Answering member
Baroness Thornton; Baroness Wheeler; Baroness Merron
Department
Department of Health and Social Care
Type
Debates on bills
Date
5 April 2022
Reference
820 cc1982-2063
House
House of Lords
Health and Care Bill

Lords report stage fourth day. Amendment 172 agreed to on division (112 to 107). Amendment 174 disagreed to on division (82 to 115). Amendment 176 agreed to. Amendment 183 agreed to on division (75 to 35). Amendment 184ZC agreed to. Amendment 184A agreed to. Amendments 185 to 187 agreed to....
Lead member
Lord Kamall; Earl Howe; Baroness Penn
Answering member
Baroness Thornton; Baroness Merron
Department
Department of Health and Social Care
Type
Debates on bills
Date
16 March 2022
Reference
820 cc370-444
House
House of Lords
Health and Care Bill

Lords report stage third day. Amendment 113 agreed to on division (205 to 155). Amendment 116 agreed to on division (207 to 169). Amendment 124 agreed to on division (210 to 169). Amendments 125, 126 and 128 to 140 agreed to. Amendment 141 agreed to on division (198 to 158)....
Lead member
Lord Kamall; Earl Howe; Baroness Penn
Answering member
Baroness Thornton; Baroness Wheeler; Baroness Merron
Department
Department of Health and Social Care
Type
Debates on bills
Date
7 March 2022
Reference
819 cc1128-1201
House
House of Lords
Medicines and Medical Devices Bill

Lords third reading. Amendment agreed to. Main Question agreed to. Bill passed and returned to the Commons with amendments.
Lead member
Lord Bethell
Answering member
Baroness Thornton
Department
Department of Health and Social Care
Type
Debates on bills
Date
21 January 2021
Reference
809 cc1280-8
House
House of Lords
Medicines and Medical Devices Bill

Lords report stage second day. Amendment 17 agreed to. Amendment 18 agreed to on division (312 to 249). Amendments 19, 22, 23, 25, 26 (new clause), 27 to 33, 35 to 38, 39 (new clause), 40 to 45, 47, 49 to 50, 54 to 62, 63 (new clause), 64, 70...
Lead member
Lord Bethell; Baroness Penn
Answering member
Baroness Thornton
Department
Department of Health and Social Care
Type
Debates on bills
Date
14 January 2021
Reference
809 cc891-976
House
House of Lords
Medicines and Medical Devices Bill

Lords second reading. Agreed to on question. Bill committed to a Grand Committee.
Lead member
Lord Bethell
Answering member
Baroness Thornton
Department
Department of Health and Social Care
Type
Debates on bills
Date
2 September 2020
Reference
805 cc370-435
House
House of Lords
Health Service Safety Investigations Bill [HL]

Lords second reading. Agreed to on question. Bill committed to a Committee of the Whole House.
Lead member
Baroness Blackwood of North Oxford
Answering member
Baroness Thornton
Department
Department of Health and Social Care
Type
Debates on bills
Date
29 October 2019
Reference
800 cc887-941
House
House of Lords
Conscientious Objection (Medical Activities) Bill [HL]

Lords second reading. Agreed to on question. Bill committed to a Committee of the Whole House.

Lead member
Baroness O'Loan
Answering member
Baroness Thornton; Baroness Chisholm of Owlpen
Department
Department of Health and Social Care
Type
Debates on bills
Date
26 January 2018
Reference
788 cc1195-1233
House
House of Lords
Health: Diabetes

To ask Her Majesty's Government how many people with type 1 diabetes who use insulin pump therapy are offered access to a dose adjustment for normal eating (DAFNE) course or an equivalent course.
Asked by
Lord Morris of Aberavon (Labour)
Type
Written questions
Status
Answered
Date
6 April 2010
Reference
2931; 718 c404WA
House
House of Lords
Health: Doctors

To ask Her Majesty's Government what research they have undertaken to ascertain the effect of gaps in junior and middle-grade doctor rotas on patient safety.
Asked by
Baroness Finlay of Llandaff (Crossbench)
Type
Written questions
Status
Answered
Date
6 April 2010
Reference
2895; 718 c407-8WA
House
House of Lords
Health: Foreign Doctors

To ask Her Majesty's Government whether their implementation of European Union rules that outlaw checks on foreign doctors' language skills takes account of risks to United Kingdom patients, as shown by the death of Mr David Gray who died as a result of being treated by a German doctor with...
Asked by
Lord Stoddart of Swindon (Independent Labour)
Type
Written questions
Status
Answered
Date
29 March 2010
Reference
2854; 718 c349WA
House
House of Lords
National Haemoglobinopathy Register

To ask Her Majesty's Government what steps have been taken to ensure that all patients with sickle cell disease and thalassaemia are on the National Haemoglobinopathy Register.
Asked by
Lord Smith of Clifton (Liberal Democrat)
Type
Written questions
Status
Answered
Date
18 March 2010
Reference
2682; 718 c225WA
House
House of Lords
National Haemoglobinopathy Register

To ask Her Majesty's Government how many people are on the National Haemoglobinopathy Register.
Asked by
Lord Smith of Clifton (Liberal Democrat)
Type
Written questions
Status
Answered
Date
18 March 2010
Reference
2681; 718 c225WA
House
House of Lords
Health: Prescription Drugs
The participants in the summit were the Association of the British Pharmaceutical Industry, the British Association of Pharmaceutical Wholesalers, the National Pharmacy Association, the Pharmaceutical Services Negotiating Committee and the Medicines and Healthcare Products Regulatory Agency, or MHRA. They agreed with my right honourable friend the Minister a more explicit duty on manufacturers and wholesalers to ensure the supply, a series of targeted inspections by the MHRA, tougher standards for the issuing of licences for medical wholesalers and the development of a best practice guide on how supply difficulties should be dealt with by doctors, pharmacies, wholesalers and manufacturers.
Answered by
Baroness Thornton (Labour)
Type
Oral answers to questions
Date
17 March 2010
Reference
718 c594
House
House of Lords
Health: Prescription Drugs
As I said in my original Answer, the supply of medicines has to be dealt with all the time and interruptions in supply can be for a variety of reasons. It has become apparent only over the last period that parallel trading, which is to do with the relationship of the pound and the euro, has become a particular issue that we particularly need to address. It is too soon to say what the effect of the summit will be, because it was only a few weeks ago, but I will certainly let the noble Baroness know.
Answered by
Baroness Thornton (Labour)
Type
Oral answers to questions
Date
17 March 2010
Reference
718 c595
House
House of Lords
Health: Prescription Drugs
The noble Baroness points to a good example of how the system can work in different ways. We have officials who spend almost all their day making sure that the supplies of medicines are in the right place at the right time for the patients.
Answered by
Baroness Thornton (Labour)
Type
Oral answers to questions
Date
17 March 2010
Reference
718 c595
House
House of Lords
Health: Prescription Drugs
My noble friend raises an important point. This matter was discussed at the summit that I referred to and is being addressed by the stakeholders and partners that took part. He is quite right. I will undertake to ensure that we are taking action on rural pharmacies and I will write to my noble friend about it.
Answered by
Baroness Thornton (Labour)
Type
Oral answers to questions
Date
17 March 2010
Reference
718 c594
House
House of Lords
Health: Prescription Drugs
I am not absolutely certain about the answer to that question. Certainly, there is a list of 40 medicines, but that is 40 medicines out of tens of thousands of licensed medicines and out of millions of prescriptions. They include drugs for some of the conditions that the noble Baroness mentioned. I am not absolutely certain whether these were sold on by the wholesalers or the manufacturers direct. I will undertake to ask that question.
Answered by
Baroness Thornton (Labour)
Type
Oral answers to questions
Date
17 March 2010
Reference
718 c595
House
House of Lords
Health: Prescription Drugs
My noble friend is right that there are stockpiles—the expression is "buffer stocks"—of essential medicines that we are building up for use in the event of pandemics or other major disruptions. The problem, as I am sure noble Lords will appreciate, is that feeding them back into the supply chain at the moment could have the opposite effect from what was intended, as it might encourage greater exporting. We are concerned not to increase the problem of parallel trading.
Answered by
Baroness Thornton (Labour)
Type
Oral answers to questions
Date
17 March 2010
Reference
718 c593-4
House
House of Lords
Health: Prescription Drugs
We think that it is unacceptable and contrary to acceptable professional behaviour for any hospital to be taking part in this. We were aware of some anecdotal reports that hospitals were trading in medicines, so the Chief Pharmaceutical Officer wrote to all chief hospital pharmacists in July 2009 and to the NHS chief executive and Monitor in February. Hospitals and NHS organisations are in absolutely no doubt that we regard this practice as unacceptable.
Answered by
Baroness Thornton (Labour)
Type
Oral answers to questions
Date
17 March 2010
Reference
718 c594
House
House of Lords